APO Research
Talk to an analyst

APO RESEARCH · REPORT

lrinotecan

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global lrinotecan Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry Researchlrinotecan Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal lrinotecan Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal lrinotecan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal lrinotecan Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal lrinotecan Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global lrinotecan market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for lrinotecan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for lrinotecan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for lrinotecan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for lrinotecan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of lrinotecan include Actiza Pharmaceutical, Cipla, Getwell, Salius, Taj Pharma, West-ward Pharmaceuticals, Pfizer and Teva, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for lrinotecan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of lrinotecan, also provides the sales of main regions and countries. Of the upcoming market potential for lrinotecan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the lrinotecan sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global lrinotecan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for lrinotecan sales, projected growth trends, production technology, application and end-user industry.

lrinotecan Segment by Company

Actiza Pharmaceutical

Cipla

Getwell

Salius

Taj Pharma

West-ward Pharmaceuticals

Pfizer

Teva

lrinotecan Segment by Type

Irinotecan Hydrochloride Injection 40mg

Irinotecan Hydrochloride Injection 100mg

Others

lrinotecan Segment by Application

Clinic

Hospital

Others

lrinotecan Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global lrinotecan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of lrinotecan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of lrinotecan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of lrinotecan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of lrinotecan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, lrinotecan sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global lrinotecan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Irinotecan Hydrochloride Injection 40mg Major Manufacturers Table 3. Irinotecan Hydrochloride Injection 100mg Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global lrinotecan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Clinic Major Manufacturers Table 7. Hospital Major Manufacturers Table 8. Others Major Manufacturers Table 9. lrinotecan Industry Trends Table 10. lrinotecan Industry Drivers Table 11. lrinotecan Industry Opportunities and Challenges Table 12. lrinotecan Industry Restraints Table 13. Global lrinotecan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global lrinotecan Revenue by Region (2021-2026) & (US$ Million) Table 15. Global lrinotecan Revenue by Region (2027-2032) & (US$ Million) Table 16. Global lrinotecan Revenue Market Share by Region (2021-2026) Table 17. Global lrinotecan Revenue Market Share by Region (2027-2032) Table 18. Global lrinotecan Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global lrinotecan Sales by Region (2021-2026) & (k units) Table 20. Global lrinotecan Sales by Region (2027-2032) & (k units) Table 21. Global lrinotecan Sales Market Share by Region (2021-2026) Table 22. Global lrinotecan Sales Market Share by Region (2027-2032) Table 23. Global lrinotecan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global lrinotecan Revenue Market Share by Manufacturers (2021-2026) Table 25. Global lrinotecan Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global lrinotecan Sales Market Share by Manufacturers (2021-2026) Table 27. Global lrinotecan Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global lrinotecan Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global lrinotecan Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global lrinotecan Manufacturers, Product Type & Application Table 31. Global lrinotecan Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global lrinotecan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global lrinotecan Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global lrinotecan Revenue by Type (2021-2026) & (US$ Million) Table 36. Global lrinotecan Revenue by Type (2027-2032) & (US$ Million) Table 37. Global lrinotecan Revenue Market Share by Type (2021-2026) Table 38. Global lrinotecan Revenue Market Share by Type (2027-2032) Table 39. Global lrinotecan Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global lrinotecan Sales by Type (2021-2026) & (k units) Table 41. Global lrinotecan Sales by Type (2027-2032) & (k units) Table 42. Global lrinotecan Sales Market Share by Type (2021-2026) Table 43. Global lrinotecan Sales Market Share by Type (2027-2032) Table 44. Global lrinotecan Price by Type (2021-2026) & (US$/unit) Table 45. Global lrinotecan Price by Type (2027-2032) & (US$/unit) Table 46. Global lrinotecan Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global lrinotecan Revenue by Application (2021-2026) & (US$ Million) Table 48. Global lrinotecan Revenue by Application (2027-2032) & (US$ Million) Table 49. Global lrinotecan Revenue Market Share by Application (2021-2026) Table 50. Global lrinotecan Revenue Market Share by Application (2027-2032) Table 51. Global lrinotecan Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global lrinotecan Sales by Application (2021-2026) & (k units) Table 53. Global lrinotecan Sales by Application (2027-2032) & (k units) Table 54. Global lrinotecan Sales Market Share by Application (2021-2026) Table 55. Global lrinotecan Sales Market Share by Application (2027-2032) Table 56. Global lrinotecan Price by Application (2021-2026) & (US$/unit) Table 57. Global lrinotecan Price by Application (2027-2032) & (US$/unit) Table 58. Actiza Pharmaceutical Company Information Table 59. Actiza Pharmaceutical Business Overview Table 60. Actiza Pharmaceutical lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Actiza Pharmaceutical lrinotecan Product Portfolio Table 62. Actiza Pharmaceutical Recent Development Table 63. Cipla Company Information Table 64. Cipla Business Overview Table 65. Cipla lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Cipla lrinotecan Product Portfolio Table 67. Cipla Recent Development Table 68. Getwell Company Information Table 69. Getwell Business Overview Table 70. Getwell lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Getwell lrinotecan Product Portfolio Table 72. Getwell Recent Development Table 73. Salius Company Information Table 74. Salius Business Overview Table 75. Salius lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Salius lrinotecan Product Portfolio Table 77. Salius Recent Development Table 78. Taj Pharma Company Information Table 79. Taj Pharma Business Overview Table 80. Taj Pharma lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Taj Pharma lrinotecan Product Portfolio Table 82. Taj Pharma Recent Development Table 83. West-ward Pharmaceuticals Company Information Table 84. West-ward Pharmaceuticals Business Overview Table 85. West-ward Pharmaceuticals lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. West-ward Pharmaceuticals lrinotecan Product Portfolio Table 87. West-ward Pharmaceuticals Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Pfizer lrinotecan Product Portfolio Table 92. Pfizer Recent Development Table 93. Teva Company Information Table 94. Teva Business Overview Table 95. Teva lrinotecan Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Teva lrinotecan Product Portfolio Table 97. Teva Recent Development Table 98. North America lrinotecan Revenue by Type (2021-2026) & (US$ Million) Table 99. North America lrinotecan Revenue by Type (2027-2032) & (US$ Million) Table 100. North America lrinotecan Sales by Type (2021-2026) & (k units) Table 101. North America lrinotecan Sales by Type (2027-2032) & (k units) Table 102. North America lrinotecan Sales Price by Type (2021-2026) & (US$/unit) Table 103. North America lrinotecan Sales Price by Type (2027-2032) & (US$/unit) Table 104. North America lrinotecan Revenue by Application (2021-2026) & (US$ Million) Table 105. North America lrinotecan Revenue by Application (2027-2032) & (US$ Million) Table 106. North America lrinotecan Sales by Application (2021-2026) & (k units) Table 107. North America lrinotecan Sales by Application (2027-2032) & (k units) Table 108. North America lrinotecan Sales Price by Application (2021-2026) & (US$/unit) Table 109. North America lrinotecan Sales Price by Application (2027-2032) & (US$/unit) Table 110. North America lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America lrinotecan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America lrinotecan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America lrinotecan Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 114. North America lrinotecan Sales by Country (2021-2026) & (k units) Table 115. North America lrinotecan Sales by Country (2027-2032) & (k units) Table 116. North America lrinotecan Sales Price by Country (2021-2026) & (US$/unit) Table 117. North America lrinotecan Sales Price by Country (2027-2032) & (US$/unit) Table 118. United States lrinotecan Revenue (2021-2032) & (US$ Million) Table 119. Canada lrinotecan Revenue (2021-2032) & (US$ Million) Table 120. Mexico lrinotecan Revenue (2021-2032) & (US$ Million) Table 121. Europe lrinotecan Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe lrinotecan Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe lrinotecan Sales by Type (2021-2026) & (k units) Table 124. Europe lrinotecan Sales by Type (2027-2032) & (k units) Table 125. Europe lrinotecan Sales Price by Type (2021-2026) & (US$/unit) Table 126. Europe lrinotecan Sales Price by Type (2027-2032) & (US$/unit) Table 127. Europe lrinotecan Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe lrinotecan Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe lrinotecan Sales by Application (2021-2026) & (k units) Table 130. Europe lrinotecan Sales by Application (2027-2032) & (k units) Table 131. Europe lrinotecan Sales Price by Application (2021-2026) & (US$/unit) Table 132. Europe lrinotecan Sales Price by Application (2027-2032) & (US$/unit) Table 133. Europe lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe lrinotecan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe lrinotecan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe lrinotecan Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 137. Europe lrinotecan Sales by Country (2021-2026) & (k units) Table 138. Europe lrinotecan Sales by Country (2027-2032) & (k units) Table 139. Europe lrinotecan Sales Price by Country (2021-2026) & (US$/unit) Table 140. Europe lrinotecan Sales Price by Country (2027-2032) & (US$/unit) Table 141. Germany lrinotecan Revenue (2021-2032) & (US$ Million) Table 142. France lrinotecan Revenue (2021-2032) & (US$ Million) Table 143. U.K. lrinotecan Revenue (2021-2032) & (US$ Million) Table 144. Italy lrinotecan Revenue (2021-2032) & (US$ Million) Table 145. Russia lrinotecan Revenue (2021-2032) & (US$ Million) Table 146. Spain lrinotecan Revenue (2021-2032) & (US$ Million) Table 147. Netherlands lrinotecan Revenue (2021-2032) & (US$ Million) Table 148. Switzerland lrinotecan Revenue (2021-2032) & (US$ Million) Table 149. Sweden lrinotecan Revenue (2021-2032) & (US$ Million) Table 150. Poland lrinotecan Revenue (2021-2032) & (US$ Million) Table 151. China lrinotecan Revenue by Type (2021-2026) & (US$ Million) Table 152. China lrinotecan Revenue by Type (2027-2032) & (US$ Million) Table 153. China lrinotecan Sales by Type (2021-2026) & (k units) Table 154. China lrinotecan Sales by Type (2027-2032) & (k units) Table 155. China lrinotecan Sales Price by Type (2021-2026) & (US$/unit) Table 156. China lrinotecan Sales Price by Type (2027-2032) & (US$/unit) Table 157. China lrinotecan Revenue by Application (2021-2026) & (US$ Million) Table 158. China lrinotecan Revenue by Application (2027-2032) & (US$ Million) Table 159. China lrinotecan Sales by Application (2021-2026) & (k units) Table 160. China lrinotecan Sales by Application (2027-2032) & (k units) Table 161. China lrinotecan Sales Price by Application (2021-2026) & (US$/unit) Table 162. China lrinotecan Sales Price by Application (2027-2032) & (US$/unit) Table 163. Asia lrinotecan Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia lrinotecan Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia lrinotecan Sales by Type (2021-2026) & (k units) Table 166. Asia lrinotecan Sales by Type (2027-2032) & (k units) Table 167. Asia lrinotecan Sales Price by Type (2021-2026) & (US$/unit) Table 168. Asia lrinotecan Sales Price by Type (2027-2032) & (US$/unit) Table 169. Asia lrinotecan Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia lrinotecan Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia lrinotecan Sales by Application (2021-2026) & (k units) Table 172. Asia lrinotecan Sales by Application (2027-2032) & (k units) Table 173. Asia lrinotecan Sales Price by Application (2021-2026) & (US$/unit) Table 174. Asia lrinotecan Sales Price by Application (2027-2032) & (US$/unit) Table 175. Asia lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia lrinotecan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia lrinotecan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia lrinotecan Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 179. Asia lrinotecan Sales by Country (2021-2026) & (k units) Table 180. Asia lrinotecan Sales by Country (2027-2032) & (k units) Table 181. Asia lrinotecan Sales Price by Country (2021-2026) & (US$/unit) Table 182. Asia lrinotecan Sales Price by Country (2027-2032) & (US$/unit) Table 183. Japan lrinotecan Revenue (2021-2032) & (US$ Million) Table 184. South Korea lrinotecan Revenue (2021-2032) & (US$ Million) Table 185. India lrinotecan Revenue (2021-2032) & (US$ Million) Table 186. Australia lrinotecan Revenue (2021-2032) & (US$ Million) Table 187. Taiwan lrinotecan Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia lrinotecan Revenue (2021-2032) & (US$ Million) Table 189. SAMEA lrinotecan Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA lrinotecan Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA lrinotecan Sales by Type (2021-2026) & (k units) Table 192. SAMEA lrinotecan Sales by Type (2027-2032) & (k units) Table 193. SAMEA lrinotecan Sales Price by Type (2021-2026) & (US$/unit) Table 194. SAMEA lrinotecan Sales Price by Type (2027-2032) & (US$/unit) Table 195. SAMEA lrinotecan Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA lrinotecan Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA lrinotecan Sales by Application (2021-2026) & (k units) Table 198. SAMEA lrinotecan Sales by Application (2027-2032) & (k units) Table 199. SAMEA lrinotecan Sales Price by Application (2021-2026) & (US$/unit) Table 200. SAMEA lrinotecan Sales Price by Application (2027-2032) & (US$/unit) Table 201. SAMEA lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA lrinotecan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA lrinotecan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA lrinotecan Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 205. SAMEA lrinotecan Sales by Country (2021-2026) & (k units) Table 206. SAMEA lrinotecan Sales by Country (2027-2032) & (k units) Table 207. SAMEA lrinotecan Sales Price by Country (2021-2026) & (US$/unit) Table 208. SAMEA lrinotecan Sales Price by Country (2027-2032) & (US$/unit) Table 209. Brazil lrinotecan Revenue (2021-2032) & (US$ Million) Table 210. Argentina lrinotecan Revenue (2021-2032) & (US$ Million) Table 211. Chile lrinotecan Revenue (2021-2032) & (US$ Million) Table 212. Colombia lrinotecan Revenue (2021-2032) & (US$ Million) Table 213. Peru lrinotecan Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia lrinotecan Revenue (2021-2032) & (US$ Million) Table 215. Israel lrinotecan Revenue (2021-2032) & (US$ Million) Table 216. UAE lrinotecan Revenue (2021-2032) & (US$ Million) Table 217. Turkey lrinotecan Revenue (2021-2032) & (US$ Million) Table 218. Iran lrinotecan Revenue (2021-2032) & (US$ Million) Table 219. Egypt lrinotecan Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. lrinotecan Distributors List Table 223. lrinotecan Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. lrinotecan Image Figure 2. Global lrinotecan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global lrinotecan Market Size Share 2021 VS 2025 VS 2032 Figure 4. Irinotecan Hydrochloride Injection 40mg Image Figure 5. Irinotecan Hydrochloride Injection 100mg Image Figure 6. Others Image Figure 7. Global lrinotecan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global lrinotecan Market Size Share 2021 VS 2025 VS 2032 Figure 9. Clinic Image Figure 10. Hospital Image Figure 11. Others Image Figure 12. Global lrinotecan Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global lrinotecan Revenue (2021-2032) & (US$ Million) Figure 14. Global lrinotecan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global lrinotecan Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global lrinotecan Revenue Market Share by Region (2021-2032) Figure 17. Global lrinotecan Sales (2021-2032) & (k units) Figure 18. Global lrinotecan Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global lrinotecan Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico lrinotecan Sales YoY (2021-2032) & (k units) Figure 21. Europe lrinotecan Sales YoY (2021-2032) & (k units) Figure 22. China lrinotecan Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) lrinotecan Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa lrinotecan Sales YoY (2021-2032) & (k units) Figure 25. Global lrinotecan Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global lrinotecan Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global lrinotecan Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global lrinotecan Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global lrinotecan Revenue Market Share by Type (2021-2032) Figure 31. Global lrinotecan Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global lrinotecan Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global lrinotecan Sales Market Share by Type (2021-2032) Figure 34. Global lrinotecan Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global lrinotecan Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global lrinotecan Revenue Market Share by Application (2021-2032) Figure 37. Global lrinotecan Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global lrinotecan Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global lrinotecan Sales Market Share by Application (2021-2032) Figure 40. North America lrinotecan Revenue Share by Type (2021-2032) Figure 41. North America lrinotecan Sales Share by Type (2021-2032) Figure 42. North America lrinotecan Revenue Share by Application (2021-2032) Figure 43. North America lrinotecan Sales Share by Application (2021-2032) Figure 44. North America lrinotecan Revenue Share by Country (2021-2032) Figure 45. North America lrinotecan Sales Share by Country (2021-2032) Figure 46. Europe lrinotecan Revenue Share by Type (2021-2032) Figure 47. Europe lrinotecan Sales Share by Type (2021-2032) Figure 48. Europe lrinotecan Revenue Share by Application (2021-2032) Figure 49. Europe lrinotecan Sales Share by Application (2021-2032) Figure 50. Europe lrinotecan Revenue Share by Country (2021-2032) Figure 51. Europe lrinotecan Sales Share by Country (2021-2032) Figure 52. China lrinotecan Revenue Share by Type (2021-2032) Figure 53. China lrinotecan Sales Share by Type (2021-2032) Figure 54. China lrinotecan Revenue Share by Application (2021-2032) Figure 55. China lrinotecan Sales Share by Application (2021-2032) Figure 56. Asia lrinotecan Revenue Share by Type (2021-2032) Figure 57. Asia lrinotecan Sales Share by Type (2021-2032) Figure 58. Asia lrinotecan Revenue Share by Application (2021-2032) Figure 59. Asia lrinotecan Sales Share by Application (2021-2032) Figure 60. Asia lrinotecan Revenue Share by Country (2021-2032) Figure 61. Asia lrinotecan Sales Share by Country (2021-2032) Figure 62. SAMEA lrinotecan Revenue Share by Type (2021-2032) Figure 63. SAMEA lrinotecan Sales Share by Type (2021-2032) Figure 64. SAMEA lrinotecan Revenue Share by Application (2021-2032) Figure 65. SAMEA lrinotecan Sales Share by Application (2021-2032) Figure 66. SAMEA lrinotecan Revenue Share by Country (2021-2032) Figure 67. SAMEA lrinotecan Sales Share by Country (2021-2032) Figure 68. lrinotecan Value Chain Figure 69. Manufacturing Cost Structure Figure 70. lrinotecan Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Irinotecan Hydrochloride Injection 40mg
  • Irinotecan Hydrochloride Injection 100mg
  • Others
Applications
  • Clinic
  • Hospital
  • Others
Companies covered
  • Actiza Pharmaceutical
  • Cipla
  • Getwell
  • Salius
  • Taj Pharma
  • West-ward Pharmaceuticals
  • Pfizer
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 lrinotecan Market by Type
  3. 1.2.1 Global lrinotecan Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Irinotecan Hydrochloride Injection 40mg
  5. 1.2.3 Irinotecan Hydrochloride Injection 100mg
  6. 1.2.4 Others
  7. 1.3 lrinotecan Market by Application
  8. 1.3.1 Global lrinotecan Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Clinic
  10. 1.3.3 Hospital
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 lrinotecan Market Dynamics
  1. 2.1 lrinotecan Industry Trends
  2. 2.2 lrinotecan Industry Drivers
  3. 2.3 lrinotecan Industry Opportunities and Challenges
  4. 2.4 lrinotecan Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global lrinotecan Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global lrinotecan Revenue by Region
  3. 3.2.1 Global lrinotecan Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global lrinotecan Revenue by Region (2021-2026)
  5. 3.2.3 Global lrinotecan Revenue by Region (2027-2032)
  6. 3.2.4 Global lrinotecan Revenue Market Share by Region (2021-2032)
  7. 3.3 Global lrinotecan Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global lrinotecan Sales by Region
  9. 3.4.1 Global lrinotecan Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global lrinotecan Sales by Region (2021-2026)
  11. 3.4.3 Global lrinotecan Sales by Region (2027-2032)
  12. 3.4.4 Global lrinotecan Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global lrinotecan Revenue by Manufacturers
  2. 4.1.1 Global lrinotecan Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global lrinotecan Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global lrinotecan Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global lrinotecan Sales by Manufacturers
  6. 4.2.1 Global lrinotecan Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global lrinotecan Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global lrinotecan Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global lrinotecan Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global lrinotecan Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global lrinotecan Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global lrinotecan Manufacturers, Product Type & Application
  13. 4.7 Global lrinotecan Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global lrinotecan Market CR5 and HHI
  16. 4.8.2 2025 lrinotecan Tier 1, Tier 2, and Tier 3
5 lrinotecan Market by Type
  1. 5.1 Global lrinotecan Revenue by Type
  2. 5.1.1 Global lrinotecan Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global lrinotecan Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global lrinotecan Revenue Market Share by Type (2021-2032)
  5. 5.2 Global lrinotecan Sales by Type
  6. 5.2.1 Global lrinotecan Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global lrinotecan Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global lrinotecan Sales Market Share by Type (2021-2032)
  9. 5.3 Global lrinotecan Price by Type
6 lrinotecan Market by Application
  1. 6.1 Global lrinotecan Revenue by Application
  2. 6.1.1 Global lrinotecan Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global lrinotecan Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global lrinotecan Revenue Market Share by Application (2021-2032)
  5. 6.2 Global lrinotecan Sales by Application
  6. 6.2.1 Global lrinotecan Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global lrinotecan Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global lrinotecan Sales Market Share by Application (2021-2032)
  9. 6.3 Global lrinotecan Price by Application
7 Company Profiles
  1. 7.1 Actiza Pharmaceutical
  2. 7.1.1 Actiza Pharmaceutical Company Information
  3. 7.1.2 Actiza Pharmaceutical Business Overview
  4. 7.1.3 Actiza Pharmaceutical lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Actiza Pharmaceutical lrinotecan Product Portfolio
  6. 7.1.5 Actiza Pharmaceutical Recent Developments
  7. 7.2 Cipla
  8. 7.2.1 Cipla Company Information
  9. 7.2.2 Cipla Business Overview
  10. 7.2.3 Cipla lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Cipla lrinotecan Product Portfolio
  12. 7.2.5 Cipla Recent Developments
  13. 7.3 Getwell
  14. 7.3.1 Getwell Company Information
  15. 7.3.2 Getwell Business Overview
  16. 7.3.3 Getwell lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Getwell lrinotecan Product Portfolio
  18. 7.3.5 Getwell Recent Developments
  19. 7.4 Salius
  20. 7.4.1 Salius Company Information
  21. 7.4.2 Salius Business Overview
  22. 7.4.3 Salius lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Salius lrinotecan Product Portfolio
  24. 7.4.5 Salius Recent Developments
  25. 7.5 Taj Pharma
  26. 7.5.1 Taj Pharma Company Information
  27. 7.5.2 Taj Pharma Business Overview
  28. 7.5.3 Taj Pharma lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Taj Pharma lrinotecan Product Portfolio
  30. 7.5.5 Taj Pharma Recent Developments
  31. 7.6 West-ward Pharmaceuticals
  32. 7.6.1 West-ward Pharmaceuticals Company Information
  33. 7.6.2 West-ward Pharmaceuticals Business Overview
  34. 7.6.3 West-ward Pharmaceuticals lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 West-ward Pharmaceuticals lrinotecan Product Portfolio
  36. 7.6.5 West-ward Pharmaceuticals Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer lrinotecan Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Teva
  44. 7.8.1 Teva Company Information
  45. 7.8.2 Teva Business Overview
  46. 7.8.3 Teva lrinotecan Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Teva lrinotecan Product Portfolio
  48. 7.8.5 Teva Recent Developments
8 North America
  1. 8.1 North America lrinotecan Market Size by Type
  2. 8.1.1 North America lrinotecan Revenue by Type (2021-2032)
  3. 8.1.2 North America lrinotecan Sales by Type (2021-2032)
  4. 8.1.3 North America lrinotecan Price by Type (2021-2032)
  5. 8.2 North America lrinotecan Market Size by Application
  6. 8.2.1 North America lrinotecan Revenue by Application (2021-2032)
  7. 8.2.2 North America lrinotecan Sales by Application (2021-2032)
  8. 8.2.3 North America lrinotecan Price by Application (2021-2032)
  9. 8.3 North America lrinotecan Market Size by Country
  10. 8.3.1 North America lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America lrinotecan Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America lrinotecan Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe lrinotecan Market Size by Type
  2. 9.1.1 Europe lrinotecan Revenue by Type (2021-2032)
  3. 9.1.2 Europe lrinotecan Sales by Type (2021-2032)
  4. 9.1.3 Europe lrinotecan Price by Type (2021-2032)
  5. 9.2 Europe lrinotecan Market Size by Application
  6. 9.2.1 Europe lrinotecan Revenue by Application (2021-2032)
  7. 9.2.2 Europe lrinotecan Sales by Application (2021-2032)
  8. 9.2.3 Europe lrinotecan Price by Application (2021-2032)
  9. 9.3 Europe lrinotecan Market Size by Country
  10. 9.3.1 Europe lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe lrinotecan Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe lrinotecan Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China lrinotecan Market Size by Type
  2. 10.1.1 China lrinotecan Revenue by Type (2021-2032)
  3. 10.1.2 China lrinotecan Sales by Type (2021-2032)
  4. 10.1.3 China lrinotecan Price by Type (2021-2032)
  5. 10.2 China lrinotecan Market Size by Application
  6. 10.2.1 China lrinotecan Revenue by Application (2021-2032)
  7. 10.2.2 China lrinotecan Sales by Application (2021-2032)
  8. 10.2.3 China lrinotecan Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia lrinotecan Market Size by Type
  2. 11.1.1 Asia lrinotecan Revenue by Type (2021-2032)
  3. 11.1.2 Asia lrinotecan Sales by Type (2021-2032)
  4. 11.1.3 Asia lrinotecan Price by Type (2021-2032)
  5. 11.2 Asia lrinotecan Market Size by Application
  6. 11.2.1 Asia lrinotecan Revenue by Application (2021-2032)
  7. 11.2.2 Asia lrinotecan Sales by Application (2021-2032)
  8. 11.2.3 Asia lrinotecan Price by Application (2021-2032)
  9. 11.3 Asia lrinotecan Market Size by Country
  10. 11.3.1 Asia lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia lrinotecan Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia lrinotecan Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA lrinotecan Market Size by Type
  2. 12.1.1 SAMEA lrinotecan Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA lrinotecan Sales by Type (2021-2032)
  4. 12.1.3 SAMEA lrinotecan Price by Type (2021-2032)
  5. 12.2 SAMEA lrinotecan Market Size by Application
  6. 12.2.1 SAMEA lrinotecan Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA lrinotecan Sales by Application (2021-2032)
  8. 12.2.3 SAMEA lrinotecan Price by Application (2021-2032)
  9. 12.3 SAMEA lrinotecan Market Size by Country
  10. 12.3.1 SAMEA lrinotecan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA lrinotecan Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA lrinotecan Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 lrinotecan Value Chain Analysis
  2. 13.1.1 lrinotecan Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 lrinotecan Production Mode & Process
  6. 13.2 lrinotecan Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 lrinotecan Distributors
  9. 13.2.3 lrinotecan Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst